Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • 2026
  • Page 1,059
exploring-visual-preferences-in-autistic-individuals
Posted inBiotechnology

Exploring Visual Preferences in Autistic Individuals

January 6, 2026
Recent research has highlighted the intricate relationship between visual preferences and cognitive processing in autistic individuals, shedding new light on…
Read More
bright-minds-shines-with-phase-2-win-for-anti-seizure-serotonin-receptor-activator
Posted inBiotechnology

Bright Minds shines with phase 2 win for anti-seizure serotonin receptor activator

January 6, 2026
Bright Minds Biosciences has debuted glowing phase 2 results for its lead anti-seizure asset, giving the biotech’s stock a jolt…
Read More
decoding-gas-release-in-battery-electrode-materials
Posted inBiotechnology

Decoding Gas Release in Battery Electrode Materials

January 6, 2026
In the relentless pursuit of safer and more efficient energy storage solutions, researchers have long sought to optimize the materials…
Read More
studying-mir172-family-in-phaseolus-vulgaris-under-metal-stress
Posted inBiotechnology

Studying miR172 Family in Phaseolus vulgaris Under Metal Stress

January 6, 2026
In a groundbreaking study recently published in BMC Genomics, researchers Öner, Aygören, Kasapoğlu, and colleagues have unveiled the intricate relationships…
Read More
boehringer-continues-kidney-disease-dealmaking-run-with-$120m-variant-bio-pact
Posted inBiotechnology

Boehringer continues kidney disease dealmaking run with $120M Variant Bio pact

January 6, 2026
Boehringer Ingelheim has unveiled its second kidney-focused collaboration in recent weeks, this time penning a deal worth over $120 million…
Read More
amgen-stitches-new-acquisition-worth-up-to-$840m-for-uk-biotech-and-its-cancer-programs
Posted inBiotechnology

Amgen stitches new acquisition worth up to $840M for UK biotech and its cancer programs

January 6, 2026
Amgen is adding Dark Blue to its tapestry, embedding the U.K. biotech’s preclinical blood cancer program into its organization. The…
Read More
arrowhead-takes-aim-at-obesity-market-with-early-data-on-dual-gene-silencing-assets
Posted inBiotechnology

Arrowhead takes aim at obesity market with early data on dual gene silencing assets

January 6, 2026
Arrowhead Pharmaceuticals has reported early-phase data on a pair of gene silencing drug candidates in obesity, posting preliminary evidence that the…
Read More
in-structure-licensing-deal,-roche-commits-$100m-to-shore-up-glp-1-position
Posted inBiotechnology

In Structure licensing deal, Roche commits $100M to shore up GLP-1 position

January 6, 2026
In a strategic move that could protect its obesity pipeline from future patent litigation, Roche is paying $100 million to…
Read More
lilly-returns-to-nimbus-with-$1.3b-deal-to-create-new-oral-obesity-drug
Posted inBiotechnology

Lilly returns to Nimbus with $1.3B deal to create new oral obesity drug

January 6, 2026
Eli Lilly has returned to Nimbus Therapeutics for another metabolic collaboration, this time focused on the red-hot R&D space of…
Read More
brainspace-garners-fda-clearance-for-brain-fluid-management-system
Posted inMedical Technology

BrainSpace garners FDA clearance for brain fluid management system

January 6, 2026
BrainSpace, a medtech focused on neurological injuries and illnesses, received 501(k) clearance from the FDA for its brain fluid management…
Read More

Posts pagination

Previous page 1 … 1,057 1,058 1,059 1,060 1,061 … 1,086 Next page

Privacy Policy    Terms

Scroll to Top